Table 1. Baseline, clinical, and laboratory characteristics of the study population (n = 60)

Variables	Pulmonary TB (n = 25)	Non-pulmonary TB (n = 35)	p
Sex
Male (n, %)	15/25 (60%)	24/35 (68.6%)
Female (n, %)	10/25 (40%)	11/35 (31.4%)
Age (mean ± SD)	57.4 ± 17.5	58 ± 17	0.782a
Symptom
Fever (n, %)	18/25 (72%)	18/35 (51.4%)	0.181b
Non-productive cough (n, %)	12/25 (48%)	12/35 (34.3%)	0.301b
Dyspnea (n, %)	8/25 (32%)	15/35 (42.9%)	0.432b
Productive cough (n, %)	8/25 (32%)	13/35 (37.1%)	0.786b
Hemoptysis (n, %)	3/25 (12%)	6/35 (17.1%)	0.722c
Chest pain (n, %)	2/25 (8%)	6/35 (17.1%)	0.449c
Definitive diagnosis
Pulmonary TB AFB (+) (n, %)	13/25 (52%)
Induced sputum (n, %)	4/25 (16%)		< 0.05c
BAL (n, %)	13/25 (52%)
Pulmonary TB AFB (-)d (n, %)	12/25 (48%)
Pneumonia (n, %)		29/35 (82.9%)
Bronchiectasis (n, %)		2/35 (5.7%)
Lung cancer (n, %)		2/35 (5.7%)
CTD-ILD (n, %)		1/35 (2.9%)
Nontuberculous mycobacteria (n, %)		1/35 (2.9%)

T-test,
Chi-square test,
Fisher’s exact test,
Histopathology confirmed pulmonary tuberculosis or MGIT culture of BAL was positive for Mycobacteria tuberculosis